A comparative study of the clinical effect of Ca-1-d1-aspartate (Calciretard), of Ca-2-aminoethanol phosphate (Ca-EAP) and of the cortisones.
D000605:Amino Alcohols; D001224:Aspartic Acid / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001847:Bone Diseases / Q000188:drug therapy*; D002128:Calcium Metabolism Disorders / Q000188:drug therapy*; D002130:Calcium Phosphates / Q000627:therapeutic use*; D003348:Cortisone / Q000627:therapeutic use*; D003649:Decalcification, Pathologic / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male
D000605:Amino Alcohols; D002130:Calcium Phosphates; D001224:Aspartic Acid; D003348:Cortisone